Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 53.23% is 11% above its 5-year average of 47.96%, around the middle of its 5-year range (38.79%–66.09%).
As of the fiscal period ended Monday, June 30, 2025. 2.48% above its 12-month average of 51.94%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
53.23%
GROSS MARGIN AVG TTM
51.94%
GROSS MARGIN AVG 3Y
46.13%
GROSS MARGIN AVG 5Y
47.05%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+2.48%
CURRENT VS 3Y AVG
+15.38%
CURRENT VS 5Y AVG
+13.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
59.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-9.92%
vs the sector median at left
23andMe Holding Co.
Market Cap
$15.31M
Gross Margin
53.23%
TTM Avg
51.94%
3Y Avg
46.13%
5Y Avg
47.05%
Market Cap
$471.59M
Gross Margin
75.48%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$1.21B
Gross Margin
68.97%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$2.64B
Gross Margin
59.09%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$2.68B
Gross Margin
48.93%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$6.19B
Gross Margin
67.64%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | $15.31M | 53.23% | 51.94% | 46.13% | 47.05% |
| NRC Health (NRC)vs › | $439.69M | 56.33% | 58.27% | 60.30% | 61.48% |
| Shoulder Innovations, Inc. (SI)vs › | $471.59M | 75.48% | 76.74% | 77.57% | 77.57% |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | 68.97% | 70.13% | 70.04% | 68.74% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 59.09% | 59.64% | 63.22% | 64.62% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | 48.93% | 50.81% | 52.12% | 52.25% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | 67.64% | 76.65% | 78.21% | 76.94% |
| Tempus AI, Inc. (TEM)vs › | $7.68B | 71.79% | 62.30% | 54.75% | 44.45% |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 17.39% | 17.24% | 38.82% | 59.22% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 51.87% | 52.87% | 53.77% | 54.60% |
Gross Margin
53.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-06-30 | 53.23% |
| 2025-03-31 | 38.79% |
| 2024-12-31 | 66.09% |
| 2024-09-30 | 50.84% |
| 2024-06-30 | 50.76% |
| 2024-03-31 | 42.22% |
| 2023-12-31 | 44.55% |
| 2023-09-30 | 43.46% |
| 2023-06-30 | 50.41% |
| 2023-03-31 | 43.28% |
| 2022-12-31 | 45.94% |
| 2022-09-30 | 50.59% |
| 2022-06-30 | 39.51% |
| 2022-03-31 | 46.80% |
| 2021-12-31 | 47.92% |
| 2021-09-30 | 50.59% |
| 2021-06-30 | 51.82% |
| 2021-03-31 | 50.27% |
| 2020-12-31 | 45.76% |
| 2020-09-30 | 47.48% |
| 2020-06-30 | 46.81% |
